Sensing of viruses by dendritic cell (DC) pathogen recognition receptors (PRRs) represents a critical event during innate antiviral immune responses. Identification of these PRRs has often posed a problem due to difficulties in performing gene function studies in the naturally targeted hosts. Consequently, we developed a lentivirus (LV)-based strategy for specific gene knockdown in porcine DC. Short hairpin RNAs (shRNAs) were designed, targeting toll-like receptor 7 (TLR7) and the adaptor protein MyD88. As cellular targets, monocyte-derived DC (MoDC) and Flt3 ligandinduced DC (Flt3L-DC), DC precursors including monocytes and haematopoietic stem cells (HSCs) as well as plasmacytoid DCs (pDCs) were employed. Transduction efficiencies ranged from 40 to 95%. The LV-mediated shRNA delivery was functionally active, reducing TLR7 and MyD88 mRNA in MoDC and conventional Flt3L-DC, and blunting the responsiveness to TLR7 ligands in Flt3L-DC. Although infection of MoDC by the LV did neither influence MHC class II and CD80/86 expressions, nor cytokine responses, the infection of Flt3L-DC induced a phenotypic maturation. Furthermore, the interaction of the LV with pDC induced high levels of interferon-a. Taken together, these studies characterize the interaction of the LV with different DC subsets and demonstrate the suitability of LV-mediated small interfering RNA delivery for targeting PRR knockout for MoDC and conventional Flt3L-DC.
Introduction
Dendritic cells (DCs) are professional antigen-presenting cells, which also play a central role in the induction of innate immune responses against virus infections. Despite their low concentration within the total leukocyte population, DCs are a major source of antiviral cytokines, which are also crucial for inducing adaptive immune responses. To fulfil these functions, DCs are particularly well equipped with pathogen recognition receptors (PRRs). 1 Ligation of the PRR, such as those recognizing viral nucleic acid, will result in DC activation and maturation. 2 However, such a general statement masks the heterogeneity of the DC system. Cytokine responses are DC subset-dependent, and in this context it is the plasmacytoid DC (pDC), which are specialized for producing particularly high levels of interferon-a (IFN-a). The so-called myeloid or conventional DC (cDC) contribute more to pro-and anti-inflammatory cytokines production such as interleukin-(IL)-6 and IL-12. 3 A number of PRRs are specialized for the recognition of viral double-stranded (ds) RNA. The (2 0 ,5 0 ) oligoadenylate synthetase and the dsRNA-dependent protein kinase R (PKR) represent enzymes initiating cascades leading to inhibition of protein synthesis and nonspecific shutdown of cellular activity. 4 There are also RNAresponsive PRRs associated with the signalling pathways leading to type I IFN production, including RNAbinding helicases such as the retinoic acid-inducible gene I (RIG-I), 5, 6 the endosomal dsRNA receptor toll-like receptor 3 (TLR3), 7 and the single-stranded (ss) RNA receptors TLR7 and TLR8. 8, 9 Viral DNA can also be recognized, by the PRR termed TLR9 which possesses specificity for DNA containing palindrome CpG motifs. [10] [11] [12] [13] Concerning TLR recognition of viral RNA and DNA, an important characteristic is the endosomal localization of these TLRs. 14 This permits the DC to detect viral nucleic acid associated with endocytic processes, without the necessity for viral replication in the DC.
All TLRs possess a cytoplasmic toll IL-1 receptor (TIR) domain, and most activate a signalling pathway involving the TIR-containing adaptor molecule MyD88. This leads to activation of the transcription factor nuclear factor kB (NF-kB) and mitogen-activated protein kinases (MAPKs), resulting in upregulation of co-stimulatory molecules and induction of cytokine secretion by the DC. 15 Most TLRs utilize the adaptor protein MyD88, although TLR3 signals independent of MyD88 through association with the alternative adaptor TRIF. 16 TLR4 can signal through both the MyD88 and the TRIF adaptor. 17 In addition to cytokine secretion, TLR activation can induce the maturation of DC. 18, 19 Analysing PRR function with respect to virus infections has focused primarily on only a few viruses that can replicate in knockout mouse models. Unfortunately, this cannot always be applied more widely to different species and the viruses specific for those species. Moreover, the distribution of TLR and the functionality of DC subsets also vary between different species. [20] [21] [22] Accordingly, an alternative to studies in knockout mouse models would be valuable. The RNA interference (RNAi) approach offers such an alternative. Through a post-transcriptional dsRNA-dependent sequence-specific gene silencing, using dsRNA homologous in sequence to the target gene, this method results in knockdown of target gene expression. 23, 24 Delivery of synthetic small interfering RNA (siRNA) duplexes or short hairpin RNAs (shRNAs) by plasmids and viral vectors has now been widely applied for disrupting human and murine cellular gene activities. 25 Despite the numerous non-viral gene delivery systems available, many show only low rates of gene transfer to DC. 26 In contrast, HIV-1 lentivirus (LV)-based vector systems pseudotyped with the vesicular stomatitis virus G protein (VSV-G) have a broad cellular tropism, and efficiently transduce many non-dividing cell types including DC. 27, 28 Considering that LV vectors stably integrate their provirus into the genomes of transduced cells, resulting in a sustained expression of the transgene, these vectors should be particularly advantageous for applying the RNAi approach in DC.
Accordingly, the present study sought to determine the feasibility of applying LV-mediated silencing of TLR signalling genes important for DC, and haematopoietic stem cell (HSC), responses.
Results

Transduction of SK6 and PK15 cells
The first goal was to test the suitability of the amphotrophic VSV-G-pseudotyped LV system for porcine cells. To this end, two porcine kidney cells lines, PK15 and SK6, were compared with the human embryonic kidney cell line 293T in terms of the pseudotyped LV transduction efficiency, measured by the frequency of enhanced green fluorescent protein (eGFP)-positive cells at 4 days post-transduction. At a multiplicity of 1 transducing unit (TU)/cell, the majority of 293T and PK15 cells were transduced, whereas SK6 cells required 10 TU cell À1 for similar levels of transduction to be reached ( Figure 1 ). None of these LV doses influenced the morphology and viability of the cells (data not shown).
Transduction of porcine bone marrow haematopoietic cell (BMHC), HSC and Flt3L-DC
The transduction efficiency of the pseudotyped LV for haematopoietic cells employed bone marrow haematopoietic cells (BMHCs), HSCs and Flt3L-DCs. Cells were infected with the recombinant LV (termed LV-THM) at various multiplicities, and eGFP expression was determined after 4 days by flow cytometry. As demonstrated by the representative experiment shown in Figure 2 , 52% of BMHCs were successfully transduced when 10 TU ml À1 were applied (Figure 2a and b) . With enriched HSC, 40% of the cells expressed eGFP at this transduction multiplicity (Figure 2c and d) . With both the BMHC and the HSC, the transduction efficiency could be increased to give around 60% eGFP + cells by superinfection with a second dose of LV-THM after 48 h (data not shown). In contrast, transduction of Flt3L-DC was already more efficient at 10 TU ml 
Transduction of monocytes and monocyte-derived DC (MoDC)
Considering the relative successful transduction efficiency observed with Flt3L-DC, the same approach was applied to blood-derived cells -monocytes and monocyte-derived DC (MoDC). With freshly isolated monocytes, the efficiency of eGFP expression was similar to that observed with the Flt3L-DC, related to transduction multiplicity (Figure 2g and h) . Transduction of the MoDC resulted in an even higher efficacy of reporter gene delivery, with over 95% cells expressing eGFP at a multiplicity of 10 TU cell À1 (Figure 2i and j). Despite this efficiency of transduction, the level of eGPF expression was relatively weak compared to 293T cells (data not shown).
Activation of cDC by LV
To determine if LV-THM was activating the porcine DC, MHC class II and CD80/86 expressions were measured on transduced MoDC and Flt3L-DC at 2 days posttransduction. As reference DC-activation controls, MoDC were treated with 1000 U ml À1 IFN-a plus 20 ng ml
À1
tumour necrosis factor (TNF)-a (termed 'I/T'); and Flt3L-DC with 10 mg ml À1 poly(I:C) (termed 'pIC'). The results demonstrated that even at the maximum multiplicity of 10 TU ml
, the LV-THM did not influence MHC class II and CD80/86 expressions on MoDC (Figure 3a) . This was not the case with the Flt3L-DC, with which an TLR7 and MyD88 knockdown in dendritic cell subsets MP Alves et al upregulation of MHC class II and CD80/86 expressions was observed, being similar to that obtained using the pIC activation control (Figure 3b) . Nevertheless, this LV-dependent activation was only observed with 10 TU ml À1 , but not with lower doses of the virus -1 and 0.1 TU cell À1 (data not shown). Moreover, the LV-THM did not induce IFN-a or IL-6 secretion by either the MoDC or the Flt3L-DC (data not shown).
Activation of pDC by LV
On the basis of these observations, it was important to determine how the LV-THM might influence pDC. This is particularly important considering the ability of pDC to respond to viruses by producing large quantities of IFN-a. Enriched pDCs were cultured in the presence of 0.1 and 1 TU cell
À1
, and after 16 h, IFN-a was measured in the supernatants. As shown in Figure 3c À , CD14 + and CD14 À fractions before transducing with 1 TU cell À1 of LV-THM. IFN-a secretion was measured in the supernatants after 16 h. These data are from two independent experiments. TLR7 and MyD88 knockdown in dendritic cell subsets MP Alves et al
Biological responses of porcine cDC to TLR ligands
To study biological responses to TLR7 ligands, it was necessary to identify a suitable readout system for TLR7-induced porcine cDC activation. Activation of MoDC by TLR ligands including R837 only induced minor phenotypic modulations of MoDC (Figure 4a ), relating to previous observations with porcine MoDC. 21 This was also seen with respect to their capacity to produce IL-6 (Figure 4c ). In contrast, the Flt3L-DC was clearly responsive to R837 in terms of both phenotypic modulation ( Figure 4b ) and IL-6 responses (Figure 4c ). This differential response of MoDC and Flt3L-DC to R837 related to the low levels of TLR7 mRNA expressed in MoDC when compared to Flt3L-DC (Figure 4d ). The unresponsiveness of MoDC and Flt3L-DC to CpG oligonucleotide (CpG ODN) in terms of CD80/86 and IL-6 secretion is also related to the relatively low mRNA levels of TLR9 in these cells, although a CpG ODN enhanced the levels of MHC class II on the Flt3L-DC (Figure 4d ). These results indicated that the porcine Flt3L-DC cultures generated contained very few or no pDC -considered to be TLR9-positive. In fact, stimulation with CpG ODN also induced no IFN-a responses in such cultures and o0.5% cells with the phenotype of porcine pDC defined as CD4 high CD172
low . 29 On the basis of these results and the potent T-cell stimulatory activity of Flt3L-DC (data not shown), the Flt3L-DC generated was classified as cDC.
LV-mediated siTLR7 delivery to MoDC and Flt3L-DC
To apply pseudotyped LV to knockdown TLR7 expression, five different siRNAs targeting TLR7 mRNA were designed. The shRNA (64-mer) were cloned in pSUPER, and the activity of the candidates screened by cotransfection of the shRNA-pSUPER plus TLR7 cDNAcloned in pEGFP.C2 -in 293T cells. Knockdown activity was monitored by measuring the eGFP fluorescence activity of the TLR7 cDNA clone by flow cytometry. Two candidate shRNAs, siTLR7.1 and siTLR7.5, were found to have silencing activity similar to a reference siGFPpositive control (Figure 5a ). Accordingly, these two candidates were analysed for their capacity to knockdown TLR7 mRNA expression in DC. To this end, the siTLR7.1 and siTLR7.5 were cloned in the LV vector transfer pLV-THM to produce the viruses for transduction. MoDC and Flt3L-DC were transduced with 10 TU ml À1 of LV-THM expressing siTLR7.1 and siTLR7.5, and TLR7 mRNA was quantified by real-time PCR at 5 days post-transduction. The siTLR7.1 and siTLR7.5 were indeed efficiently expressed, as witnessed by the 490% knockdown of TLR7 mRNA levels compared with cells transduced by empty LV (LV-THM) and LV expressing control siRNA (siNEG). This level of knockdown was observed for both MoDC and Flt3L-DC (Figure 5b ). The silencing was specific for TLR7 as shown by the unchanged TLR9 mRNA levels in MoDC and Flt3L-DC transduced with LV bearing siTLR7.1 and siTLR7.5 (Figure 5c ).
Considering the fact that the LV itself modulates MHC class II and CD80/86 expression (Figure 3b) but not IL-6 secretion, it was decided to use the latter as a readout system for TLR7-mediated DC activation. When Flt3L-DC transduced with LV-THM expressing siTLR7.1 and siTLR7.5 was stimulated with R837 for 16 h, IL-6 secretion was abrogated. This silencing of the Flt3L-DC for TLR7 expression was confirmed by their inability to mount a response to a second TLR7 ligand -poly(U). Furthermore, the silencing was specific for TLR7, as witnessed by the unimpeded response to lipopolysaccharide (LPS) (Figure 5d ).
LV-mediated siMyD88 delivery to MoDC and Flt3L-DC
Considering the importance of the adaptor protein MyD88 in many TLR signalling pathways, siRNAs were designed against MyD88. Six different shRNAs were cloned in the LV-THM transfer vector, and viruses produced. MoDC or Flt3L-DC was then transduced with 10 TU ml
À1
, and MyD88 mRNA was quantified by realtime PCR at 5 days post-transduction (Figure 6a ). Two functional siRNA candidates, siMyD88.7 and siMyD88.9, were identified and reduced MyD88 mRNA levels by 480% compared to negative controls including empty LV-THM, siNEG and a medium control.
To demonstrate a loss of biological function triggered by the two siMyD88 candidates, the Flt3L-DC model was again employed. When the Flt3L-DCs were transduced with LV expressing siMyD88.7 or siMyD88.9, their capacity to respond to the TLR7 ligand R837 was abrogated (Figure 6b) . Consistent with the involvement of MyD88 in many TLR signalling pathways, these siRNAs were also able to knockdown signalling induced by the TLR4 ligand LPS (Figure 6b) . Furthermore, the silencing was specific for MyD88, as witnessed by the 
Discussion
TLR7 is reported to represent an important ssRNA recognition receptor, and on this basis would play an important role in the innate recognition of RNA viruses. Nevertheless, a role for TLR7 in sensing viruses has only been clearly demonstrated for influenza virus and VSV virus following infection of pDC. 8, 30 These studies were performed using either mice deficient in TLR7, or genetic complementation studies with human HEK293 cells. Unfortunately, the murine knockout approach is not applicable for many human and veterinary viruses, which show a high species specificity. Genetic complementation studies in cell lines also have their limitations when specific primary cell targets are to be studied. For example, critical biological differences exist between cell lines and DC, particularly receptor expression, endocytic activity and relative activities of individual PRR. Consequently, the role of TLRs -especially TLR3, TLR7 and TLR9 -in the innate immune responses against many viruses requires further investigations. For this purpose, we have established an RNAi approach, which can be used to clarify the role of TLRs and other PRRs in the porcine innate immune response against pathogens.
VSV-pseudotyped LV possess a wide tropism for various cell types from several species. [31] [32] [33] [34] These viruses have also been employed successfully to deliver exogenous genes to human cDC. [35] [36] [37] [38] A major advantage of this vector system is its capacity to mediate stable foreign gene expression in non-dividing cells -a prerequisite for studies on DC activity. Furthermore, studies on the interaction of such vectors with DC did not indicate a functional activation or perturbation of the DC function. 35, 39, 40 Although non-viral gene delivery to DC using electroporation and lipofection shows only low transfection efficiencies for plasmid DNA, 41 satisfactory transfection efficiency for RNA molecules has been obtained. [42] [43] [44] Nevertheless, both dsRNA and ssRNA, including siRNA, can activate cDC and pDC through ligation of RNA sensing PRR. [45] [46] [47] [48] Consequently, we sought to apply LV-mediated delivery of shRNA to DC.
In the present study, we have demonstrated that LV vectors are generally applicable for transgene delivery in porcine DC and HSC. Furthermore, we demonstrate their efficiency at delivering siRNA to cDC generated from monocytes or BMHC (MoDC and Flt3L-DC). The TLR7 and MyD88 knockdown in dendritic cell subsets MP Alves et al delivered siRNA was functional as witnessed by the efficient silencing of TLR7 and MyD88. Despite the clear applicability of LV-vectored siRNA to cDC, the situation was not so straightforward when pDCs were targeted. With this DC subset, the LV vector induced large quantities of IFN-a. This observation is in accordance with recent reports indicating that HIV-1 activates pDC to produce IFN-a, possibly through TLR7. 49, 50 With the LV-delivered siRNA requiring a number of days before knockdown is observable, this is an additional problem with pDCs -these cells rapidly lose their ability to produce IFN-a after culture-induced differentiation. 3 An alternative approach would be the delivery of siRNA by lipofection. However, this method can only be used with certain non-stimulatory siRNA sequences, the characteristics of which are unclear. 48 Another possible approach is to target pDC by transducing BMHC with the LVvectored siRNA before differentiation of the cells into pDC. When using Flt3L, BMHC can be induced to differentiate into both cDC and pDC. 51 There are currently two obstacles to overcome. First, in the porcine system, we have not been able to generate sufficient pDC using the Flt3L-induced differentiation protocols described for human and mouse BMHC. Also high concentration of Flt3L did not induce more than 2% pDC in such cultures (data not shown). The second hindrance was that the efficiency of knockdown after transduction of BMHC before their differentiation into DC would depend on the transduction efficiency in stem cells. As this was limited to 40% using the present LV vector system, it can be anticipated that a maximum of 40% knockdown is currently achievable, relating to the results we also observed using this protocol (data not shown). An improvement of transduction efficiency by constructing novel LV vectors with improved stem cell targeting might give the solution to this problem. This report is also the first to describe porcine Flt3L-derived DC. Although in this species the differentiation of functional cDC using this cytokine was efficient, no or very few pDCs were obtained. At no time of harvesting such cultures more than 2% pDCs were identified (data not shown). This was found with various concentrations of Flt3L used. An explanation for this observation would be that porcine pDC generation from BMHC requires additional cytokines. The high levels of TLR7 in the porcine Flt3L-DC is not a contradiction to the infrequency of pDC and relates to a similar observation found with human Flt3L-derived cDC showing high levels of IL-6 production in response to a TLR7 ligand. 52 In conclusion, the present work has demonstrated that LV vectors are efficient delivery vehicles for targeting siRNA to DC, although one has to be aware of the activating capacity of the LV. The delivery of siRNA can be used for efficient gene silencing in porcine haematopoietic cells. We consider that this system has high applicability for studies on PRR function in DC with respect to sensing virus infections. The general importance of DC and HSC for immune responses and haematopoiesis, combined with the pig as a particularly useful large animal model, will make such developments also of value for gene therapy and transplantation studies.
Materials and methods
Monoclonal antibodies (mAbs) and flow cytometry
Monoclonal antibodies (Mabs) against CD4 (PT90A), CD14 (Cam36A) and MHC class II (TH16B) were purchased from VMRD (Pullmann, WA, USA). AntiCD172a (74-22-15A) was kindly provided by Dr Armin Saalmü ller (Veterinärmedizinische Universität Wien, Wien, Austria). CD80/86 expression was measured using a human CTLA4-mouse immunoglobulin fusion protein (Alexis, Switzerland). 53 Reactions of the mAbs were revealed using isotype-specific fluorescein isothiocyanate (FITC)-, RPE-or biotin-conjugated anti-mouse immunoglobulin F(ab')2 fragments (Southern Biotechnology Associates Inc., Birmingham, AL, USA). Biotinylated conjugates were developed with streptavidin-Cy5. TLR7 and MyD88 knockdown in dendritic cell subsets MP Alves et al subtraction algorithm. This algorithm essentially subtracts histograms on a channel-by-channel basis to provide a percent of positive cells. 54 
MoDC generation
MoDCs were generated as described previously. 55 Briefly, PBMCs were obtained by density-gradient centrifugation over Ficoll-Paque (1.077 g l À1 , Amersham Biosciences, Uppsala, Sweden), 56 and CD172a + monocytes purified using magnetic antibody cell sorting (MACS; Miltenyi Biotech, Gladbach, Germany) with anti-CD172a mAb (clone 74-22-15; ATCC, Manassas, VA, USA). Monocytes were plated in 6-well plates at a concentration of 10 6 cells ml À1 in Dulbecco's modified Eagle's medium (DMEM; Invitrogen, Basel, Switzerland) containing 10% (v/v) porcine serum (Sigma Chemicals, Buchs, Switzerland). Cells were fed at days 0 and 2 with 100 U ml À1 recombinant porcine granulocyte/macrophage colony-stimulating factor (GM-CSF) and 100 U ml À1 recombinant porcine IL-4 both prepared in our laboratory as described previously. 57, 58 After 4 days, loosely adherent and non-adherent cells were harvested.
Isolation of BMHC and HSC
BMHCs were isolated from the sternum of 3-6-week-old pigs as described previously, 59 followed by a depletion of erythrocytes and mature granulocytes using densitygradient centrifugation (1000 g, 40 min) over FicollPaque. HSCs were enriched by MACS sorting for c-Kit expressing BMHC as described previously. 58 Generation of BMHC-derived DC using Flt3 ligandinduced DC (Flt3L-DC)
For the generation of Flt3L-DC, BMHCs were plated in 6-well plates at a rate of 5 Â 10 5 cells ml À1 in Iscove's modified Dulbecco's medium (Invitrogen) containing 10% fetal bovine serum (Sigma Chemicals), supplemented with antibiotics (penicillin/streptomycin, Invitrogen) and human Flt3L (20 ng ml
À1
; R&D Systems, Minneapolis, MN, USA). Cells were fed every 3-4 days with Flt3L (20 ng ml À1 ). After 15 days, the non-adherent cell population, which was dominated by cells with DC morphology, was collected.
pDC isolation
For enrichment of pDC, CD172a + cells were isolated from PBMC by MACS using LD columns as described previously. 21 This cell population is composed of monocytes (80-90%), conventional blood DC (2-5%) and pDC (2-5%).
Design and cloning of shRNAs
Putative siRNAs sequences were chosen using the iRNAi program developed by Mek and Tosj from The Netherlands Cancer Institute (http://mekentosj.com). shRNA (64-mer; Sigma-Genosys, London, UK) were cloned into pSUPER (Oligoengine, Seattle, WA, USA) using SacIIBglII restriction sites. Putative shRNA were screened for knockdown activity by co-transfection of 293T cells (ATCC, Manassas, VA, USA) with pSUPER-shRNA and pEGFP.C2 (Clontech, Palo Alto, CA, USA) encoding an open reading frame of eGFP and the target gene. The intensity of eGFP fluorescence was measured by flow cytometry analysis 48 h post-transfection. Putative siRNAs were identified on the basis of 475% reduced eGFP geometric fluorescence intensity. Then, the H1-shRNA cassettes were excised from pSUPER by using EcoRI-ClaI restriction sites and cloned in the pLV-THM transfer vector (kindly provided by Dr Didier Trono, Ecole Polytechnique Fédérale de Lausanne, Switzerland). This vector expresses eGFP under the control of the EF1a promoter, and the siRNA under the control of the histone 1 polymerase III-dependent promoter, and is used for subsequent LV generation. 60 The following were the sequences of functional siRNA used in our study. siTLR7.1, 5 0 -CCATGGAGAGCGAATCGCT-3 0 ; siTLR7.5, 5
0 -GCCTCAAGAAACTCATACT-3 0 ; siMyD88.7, 5 0 -ATGC CTGAGCATTTTGATG-3 0 ; and siMyD88.9, 5 0 -GAGGA CTGCCGAAAGTATA-3 0 . The negative controls (siNEG) for the exclusion of nonspecific effects of siRNA are putative siTLR7 and siMyD88 candidates without any observed knockdown activity and have the following sequence: siNEG for TLR7, 5
0 -TGGGCTCAAGTCTTT CAAT-3 0 ; siNEG for MyD88, 5 0 -CTGCCCCAGCGA TATCCAG-3 0 .
Production of LV
All recombinant LV were produced by transient transfection of 293T cells according to standard protocols. 61 Briefly, subconfluent 293T cells (30-40%) were cotransfected using the calcium phosphate precipitation method with 20 mg of transfer plasmid (pLV-THM) containing the shRNA (termed pLV-THM.siGENE), 15 mg of packaging plasmid (pCMV-DR8.91), and 5 mg of envelope vector (pMD2G-VSVG). After 16 h, the medium was changed, and 24 h later the supernatants harvested, filtered through 0.45 mm pore-sized membranes, concentrated by ultracentrifugation and resuspended in DMEM 10% FBS. Viral stocks were aliquoted and stored at À701C. Transduction efficiency and infectious titres were determined with SK6 cells seeded at 2 Â 10 5 cells well À1 in 6-well plates 1 day before transduction. Serial dilutions of vector preparations were added to the SK6 cells, and the percentage of eGFP + cells measured by flow cytometry at 48-72 h post-transduction. Numerous titre determinations have shown that the percentage of transduced cells correlates linearly with the vector input when the percentage is lower than 15%. Therefore, all titres were based on three values lower than 15% and showing the expected linearity. The infectious titres were expressed as SK6 TU ml
À1
.
RNA isolation and quantitative reverse transcriptionpolymerase chain reaction (RT-PCR)
Total cellular RNA was prepared using RNeasy mini kit (Qiagen, Hombrechtikon, Switzerland) and treated with RNase-free DNase I (Ambion, Huntingdon, UK). The reverse transcription-polymerase chain reaction (RT-PCR) measurements were performed using the ABI PRISM 7700 sequence Detector system (Applied Biosystems, Foster City, CA, USA). The relative expression of each mRNA was calculated by the DC t method, and the amount of target mRNA relative to 18S mRNA was expressed as 2
ÀCt
). 62 Data are presented as the ratio of target mRNA to 18S mRNA. The following were the primers and probes employed. TLR7 forward primer, 5 0 -CAGAAGTCCAAGTTTTTCCAGCTT-3 0 ; TLR7 reverse primer, 5
0 -GGTGAGCCTGTGGATTTGTTG-3 0 ; TRL7 
Cytokine responses
DCs were stimulated with the following: R837 at 10 mg ml À1 (Invivogen, San Diego, CA, USA); CpG ODN D32 at 10 mg ml À1 (Invitrogen, San Diego, CA, USA); Poly(U), LPS and poly(IC) at 10 mg ml À1 (Sigma Chemicals, St Louis, MA, USA). Quantification of IFN-a in cell culture supernatants was by enzyme-linked immunobsorbant assay (ELISA) as described elsewhere, 21 using anti-pig IFN-a mAb K9 (R&D Systems, Minneapolis, MN, USA) as capture antibody and biotinylated anti-pig IFN-a mAb F17 (kindly donated by Dr Bernard Charley, INRA, Jouy-en-Josas, France) as detection antibody. IL-6 levels in the supernatants were quantified by ELISA using the DuoSet kit from R&D Systems (Minneapolis, MN, USA).
